Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Treace Medical Concepts Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Treace Medical Concepts Inc (TMCI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-4.24 %
Q2 2026
Net Margin
-34.98 %
Q2 2026

Key Findings: Treace Medical Concepts Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 205M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-11.6% annualized vs trailing 12 months).
  • Scale: Treace Medical Concepts Inc ranks #98 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
  • Peer revenue share: Treace Medical Concepts Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

TMCI Sales vs. its Competitors, Q2 2026

Treace Medical Concepts Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/TMCI/competitors
https://api.csimarket.com/api/v1/companies/TMCI/relationships
https://api.csimarket.com/api/v1/companies/TMCI/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.1% year over year, combined, vs -4.2% for Treace Medical Concepts Inc. Treace Medical Concepts Inc's share of combined industry revenue moved from 0.05% to 0.04%, a loss of 0.01 percentage points.

Treace Medical Concepts Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Treace Medical Concepts Inc No No No No
High-Confidence Competitors (1) 0% 100% 100% 0%
Similar-Size Competitors (10) 44% 56% 44% 44%
Similar Growth & Profitability (8) 12.50 % (1 of 8) 75.00 % (6 of 8) 50.00 % (4 of 8) 37.50 % (3 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Treace Medical Concepts Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Treace Medical Concepts Inc and its 0 tracked competitors.

See Treace Medical Concepts Inc's full market share breakdown »

TMCI Stock Performance relative to its Competitors

TMCI Competitors (weighted) Percent change over the selected range

Treace Medical Concepts Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
100%beat U.S.A. 500
High-Confidence
(1 of 1)
40%beat U.S.A. 500
Similar-Size
(4 of 10)
42.9%beat U.S.A. 500
Similar Growth & Profitability
(3 of 7)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Treace Medical Concepts Inc -35.10 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (7) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Treace Medical Concepts Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

TMCI Stock Performance relative to High-Confidence Competitors

TMCI High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

TMCI Stock Performance relative to Similar-Size Competitors

TMCI Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

TMCI Stock Performance relative to Similar Growth & Profitability Competitors

TMCI Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Treace Medical Concepts Inc's Comment on Competition and Industry Peers

The company offers surgeon education and training programs, including simulated surgical workshops and advanced training. It holds exclusive licenses and owns multiple U.S. trademarks related to its products. The company recognizes that numerous U.S. and foreign-issued patents and patent applications owned by third parties exist in its field, which may present competitive challenges. It also acknowledges the possibility that competitors could develop treatment methods or devices not covered by its patents. Additionally, the company notes the prevalence of substantial litigation concerning patent and intellectual property rights within the medical device industry.

Treace Medical Concepts Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Paragon 28 inc Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Treace Medical Concepts Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License